Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Update

Polyrizon Ltd. (NASDAQ:PLRZ) was the target of a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 51,385 shares, a decrease of 57.2% from the January 15th total of 120,032 shares. Currently, 4.9% of the company’s stock are short sold. Based on an average trading volume of 71,761 shares, the short-interest ratio is currently 0.7 days. Based on an average trading volume of 71,761 shares, the short-interest ratio is currently 0.7 days. Currently, 4.9% of the company’s stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Polyrizon in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Polyrizon Trading Down 3.1%

Polyrizon stock traded down $0.44 during trading hours on Friday, hitting $13.55. The stock had a trading volume of 17,283 shares, compared to its average volume of 134,132. Polyrizon has a fifty-two week low of $2.88 and a fifty-two week high of $2,235.00. The company has a 50-day moving average of $12.32 and a two-hundred day moving average of $8.34.

Hedge Funds Weigh In On Polyrizon

An institutional investor recently bought a new position in Polyrizon stock. Jane Street Group LLC acquired a new position in Polyrizon Ltd. (NASDAQ:PLRZ) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned about 1.35% of Polyrizon at the end of the most recent reporting period.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.